The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2A trial of Ad5.F35-GUCY2C-PADRE vaccine for recurrence prevention in gastrointestinal (GI) adenocarcinomas post definitive surgery and adjuvant therapies.
 
Babar Bashir
Consulting or Advisory Role - Merck/Eisai
Research Funding - Amgen (Inst); Artios (Inst); Bicycle Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo/Lilly (Inst); Elucida Oncology (Inst); Gritstone Bio (Inst); Ikena Oncology (Inst); Jazz Pharmaceuticals (Inst); KAHR Medical (Inst); Lyell Immunopharma (Inst); Merck (Inst); Pionyr (Inst); RasCal (Inst); Syros Pharmaceuticals (Inst); Tarveda Therapeutics (Inst)
 
Edith P. Mitchell
Leadership - Corvus Pharmaceuticals
Honoraria - Exelixis; Sanofi
Consulting or Advisory Role - Bristol Myers Squib; Genentech; Merck; Novartis
Speakers' Bureau - Ipsen
Research Funding - Genentech (Inst); sanofi (Inst)
 
James Posey
Consulting or Advisory Role - Lilly; Seagen
 
Atrayee Basu Mallick
Stock and Other Ownership Interests - Alexion Pharmaceuticals (I); BMS (I); Pfizer (I)
Consulting or Advisory Role - Bayer; deciphera; deciphera; Novartis
Research Funding - Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Prelude Therapeutics (Inst); Prelude Therapeutics (Inst); PTC therapeutics (Inst); Pyramid Biosciences (Inst); Rgenix (Inst); The Academic GI Cancer Consortium (Inst); TRACON Pharma (Inst)
 
Daniel Lin
Stock and Other Ownership Interests - BioNano Genomics
Honoraria - Exelixis
Consulting or Advisory Role - Exelixis; Exelixis; Exelixis/Ipsen
 
Rajan Singla
No Relationships to Disclose
 
Eduardo Fernandez
No Relationships to Disclose
 
Michael J. Ramirez
No Relationships to Disclose
 
Jagmohan Singh
No Relationships to Disclose
 
Walter K. Kraft
Honoraria - Sun Pharma
Consulting or Advisory Role - 3D communications
Research Funding - Merck (Inst)
 
Madison Crutcher
No Relationships to Disclose
 
Daniel S. Lefler
No Relationships to Disclose
 
Benjamin E. Leiby
Consulting or Advisory Role - Alpha TAU Medical
Research Funding - GlaxoSmithKline (Inst)
 
Tingting Zhan
No Relationships to Disclose
 
Scott A. Waldman
Employment - Targeted Diagnostics & Therapeutics
Leadership - Targeted Diagnostics & Therapeutics
Honoraria - Synergy Pharmateuticals
Speakers' Bureau - Synergy Pharmateuticals
Research Funding - Synergy Pharmateuticals (Inst); Targeted Diagnostics & Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I have >100 patents held by Thomas Jefferson University
Expert Testimony - Bausch Health
Travel, Accommodations, Expenses - Synergy Pharmateuticals
(OPTIONAL) Uncompensated Relationships - Targeted Diagnostics & Therapeutics
 
Adam E. Snook
Employment - Vittoria Biotherapeutics
Stock and Other Ownership Interests - Targeted Diagnostics & Therapeutics; Vittoria Biotherapeutics
Consulting or Advisory Role - Targeted Diagnostics & Therapeutics
Research Funding - Targeted Diagnostics & Therapeutics
Patents, Royalties, Other Intellectual Property - I am an inventor on patents licensed to Targeted Diagnostics and Therapeutics.